SNHG3 and neutropenia: SNHG3 promotes PD1 expression by regulating ASF1B. Ultimately, elevated ASF1B predicted poor outcomes for HCC patients in subgroups with B cells, CD8+ T cells, or neutropenia, and in subgroups with CD4+ T cell enrichment.